课题基金 / 基金详情

Development of 14-3-3 protein/protein interaction agonists as potential therapies for spinal cord injury and stroke

Development of 14-3-3 protein/protein interaction agonists as potential therapies for spinal cord injury and stroke
开发 14-3-3 蛋白质/蛋白质相互作用激动剂作为脊髓损伤和中风的潜在疗法
批准号：
409940
负责人：
Gleason James L
金额：
$20.9万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-09-01 至 2022-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=409940&lang=en
关键词：
14-3-3 Protein Fusiccocin A Gcn1 Protein/Protein Interaction Virtual Screening

项目摘要

项目成果

Gleason James L的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
14-3-3 Adaptor proteins are species which act as molecular chaperones for other proteins in cells. They bind to proteins and this affects the function of the target protein. Fusicoccin A is a naturally occurring molecule which facilitates the binding of 1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bifunctional non-secosteroidal vitamin D analogues as novel cancer therapeutics
  • 批准号：
    358624
  • 项目类别：
    Operating Grants
  • 资助金额：
    $29.26万
  • 财政年份：
    2016
  • 负责人：
    Gleason James L
  • 依托单位：
    McGill University
Novel bivalent hybrid molecules with retinoic acid receptor agonistic and histone deacetylase inhibitory activity for cancer treatment
  • 批准号：
    226244
  • 项目类别：
    Operating Grants
  • 资助金额：
    $25.85万
  • 财政年份：
    2011
  • 负责人：
    Gleason James L
  • 依托单位：
    McGill University